MedElevator Войти в исследования
← Поиск публикаций

DOI 10.7150/thno.116970

Медицинская библиотека · Theranostics · 2026

Dissolvable microneedles loaded with denosumab alleviate knee osteoarthritis in rodent and canine models by inhibiting macrophage senescence.

Ming Chaochang, Bi Duohang, Tian Hongtao, Liu Weijian, Li Haitao, Hu Yuxiang, Song Zhenyu, Xu Dongdong, Xu Hao, Li Hongyan, Lan Shenghui, Xu Weihua, Chen Wei, Li Qiong, Feng Jiawei, Cao Qianqian, Wang Xiaoyang, Fan Panlong, Zhu Jintao, Yu Wei, Ming Chaoge, Dai Zhipeng, Liu Yijing, Tong Wei

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Rationale: Osteoarthritis (OA) lacks disease-modifying therapies. Although systemic denosumab delays OA progression, it causes uneven drug distribution and off-target effects, whereas intra-articular injections are invasive and risk joint infection. We aimed to develop a minimally invasive microneedle platform that delivers denosumab locally to achieve therapeutic efficacy comparable to intra-articular injection while avoiding systemic exposure.

Methods

A dissolvable denosumab-loaded microneedle array (MNs@De) was fabricated for transcutaneous intra-articular delivery. OA was induced in rodents and Beagle dogs; animals were treated with MNs@De, systemic denosumab, intra-articular denosumab, or vehicle. Synovial inflammation, cartilage erosion, and pain were evaluated histologically and behaviorally. Single-cell RNA sequencing and immunofluorescence were performed to assess macrophage senescence and chondrocyte metabolism. Secretion of pro-inflammatory and catabolic factors was quantified in vitro using senescent macrophage-chondrocyte co-cultures.

Results

MNs@De delivered denosumab effectively into joints, significantly reducing synovial inflammation, cartilage erosion, and pain compared with systemic administration and achieving outcomes comparable to intra-articular injection. Single-cell profiling revealed that denosumab markedly decreased senescent macrophage abundance within synovial tissue. Mechanistically, denosumab inhibited senescent macrophage-derived pro-inflammatory and catabolic factor release, thereby shifting chondrocytes from catabolic to anabolic states.

Conclusions

Targeting senescent macrophages via MNs@De attenuates OA progression without requiring intra-articular injections or increasing systemic drug exposure. Microneedle-mediated denosumab delivery offers a minimally invasive, localized therapeutic strategy for OA.

Для цитирования: Ming Chaochang, Bi Duohang, Tian Hongtao, Liu Weijian, Li Haitao, Hu Yuxiang, Song Zhenyu, Xu Dongdong, Xu Hao, Li Hongyan, Lan Shenghui, Xu Weihua, Chen Wei, Li Qiong, Feng Jiawei, Cao Qianqian, Wang Xiaoyang, Fan Panlong, Zhu Jintao, Yu Wei, Ming Chaoge, Dai Zhipeng, Liu Yijing, Tong Wei. Dissolvable microneedles loaded with denosumab alleviate knee osteoarthritis in rodent and canine models by inhibiting macrophage senescence.. Theranostics. 2026. DOI: 10.7150/thno.116970.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.